EU Proposal Gives Tissue Firms Only Two Years To Comply With New Regs

Companies that market human tissue-engineered products (hTEP) in the European Union say they are alarmed by a new proposal from the European Commission that will give them only two years to comply with revised premarket regulations

More from Archive

More from Medtech Insight